Nucleotide metabolism and ADPase activity in cardiac and renal transplantation.
Caillard
S
S
Inserm U311 and Service de Néphrologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Charpentier
A
A
Ravannat
C
C
Cassel
D
D
Wiesel
M L
ML
Moulin
B
B
Cazenave
J P
JP
Gachet
C
C
D000328:Adult; D015703:Antigens, CD / Q000097:blood; D001081:Apyrase / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D001792:Blood Platelets / Q000201:enzymology; D018957:CD59 Antigens / Q000097:blood; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000502:physiology; D005260:Female; D016027:Heart Transplantation / Q000276:immunology / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D008875:Middle Aged; D017395:Plasminogen Activator Inhibitor 1 / Q000097:blood; D012016:Reference Values; D010959:Tissue Plasminogen Activator / Q000097:blood; D014841:von Willebrand Factor / Q000032:analysis
D015703:Antigens, CD; D015415:Biomarkers; D018957:CD59 Antigens; D007166:Immunosuppressive Agents; D017395:Plasminogen Activator Inhibitor 1; D014841:von Willebrand Factor; D010959:Tissue Plasminogen Activator; D001081:Apyrase; C067869:CD39 antigen